Skip to content
Subscriber Only

Edwards Profit Rises on Strong Demand for Heart Valves

Edwards Lifesciences Corp., a maker of heart valves, said second-quarter profit increased 39 percent on greater demand for devices that replace a damaged aortic valve without cracking open the chest.

Net income rose to $94.1 million, or 82 cents a share, from $67.8 million, or 57 cents, a year earlier, the Irvine, California-based company said today in a statement. Earnings excluding one-time items of 82 cents a share beat the 76 cents average of 22 analysts’ estimates compiled by Bloomberg. Revenue increased 7.3 percent to $517.2 million, topping the consensus estimate of $514.4 million.